Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Role of Reduced Coenzymes NADH and FADH₂01:29

Role of Reduced Coenzymes NADH and FADH₂

11.5K
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
11.5K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

544
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
544
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

7.4K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
7.4K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

660
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
660
Cofactors and Coenzymes01:27

Cofactors and Coenzymes

81.4K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
81.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A metabolomic signatures in hyperuricemia: a systematic review.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

[Retracted] Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway.

International journal of oncology·2026
Same author

Association between hemoglobin-to-red cell distribution width ratio and occurrence of sepsis during ICU stay in inflammatory bowel disease patients who died: a retrospective study using the EICU-CRD database.

PloS one·2026
Same author

Multi-omics reveals novel CYP450s and transcription factors regulating triterpenoid biosynthesis in Aralia elata.

Plant science : an international journal of experimental plant biology·2026
Same author

Resveratrol attenuates sepsis-induced lung injury by suppressing NLRP3-mediated pyroptosis.

Shock (Augusta, Ga.)·2026
Same author

Integrating UHPLC-Q-TOF/MS and multi-omics to elucidate the regulatory mechanisms of Xiong's Shiwei Wendan decoction in MASLD.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026

Related Experiment Video

Updated: Jun 30, 2025

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

8.4K

Coenzyme Q10 in atherosclerosis.

Minjun Liao1, Xueke He2, Yangyang Zhou1

  • 1Institute of Cardiovascular Disease, Department of Pathophysiology, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical College, University of South China, Hengyang, 421001, PR China; Department of Clinical Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, PR China.

European Journal of Pharmacology
|March 17, 2024
PubMed
Summary
This summary is machine-generated.

Coenzyme Q10 (CoQ10) demonstrates protective effects against atherosclerosis, a major cause of cardiovascular death. Research indicates CoQ10 may mitigate key disease processes, suggesting its therapeutic potential.

Keywords:
AtherosclerosisCoenzyme Q10InflammationLipid metabolismOxidative stress

More Related Videos

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

2.3K
Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools
05:27

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools

Published on: July 20, 2022

1.9K

Related Experiment Videos

Last Updated: Jun 30, 2025

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

8.4K
Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

2.3K
Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools
05:27

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools

Published on: July 20, 2022

1.9K

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Nutritional Science

Background:

  • Atherosclerosis is a leading cause of global cardiovascular mortality, particularly in the elderly.
  • Key pathological processes include abnormal lipid metabolism, endothelial dysfunction, inflammation, and oxidative stress.
  • Coenzyme Q10 (CoQ10) is an essential mitochondrial component and potent antioxidant.

Purpose of the Study:

  • To review the role of CoQ10 in the electron transport chain and its antioxidant functions.
  • To explore CoQ10's physiological impact on oxidative stress, inflammation, lipid metabolism, and autophagy.
  • To assess CoQ10's therapeutic potential in mitigating atherosclerosis progression.

Main Methods:

  • Literature review of CoQ10's forms in the electron transport chain.
  • Analysis of CoQ10's physiological regulatory roles.
  • Examination of molecular mechanisms, animal models, and clinical evidence of CoQ10 in atherosclerosis.

Main Results:

  • CoQ10 mitigates lipid transport abnormalities, endothelial inflammation, metabolic disturbances, and thrombotic processes in atherosclerosis.
  • Evidence from molecular, animal, and clinical studies supports CoQ10's beneficial effects.
  • Combined CoQ10 therapy shows synergistic effects with other drugs.

Conclusions:

  • CoQ10 exhibits significant potential as a therapeutic agent for atherosclerotic cardiovascular diseases.
  • Further basic and clinical research is warranted to fully establish CoQ10's role in treatment.
  • CoQ10 may offer a novel strategy to combat cardiovascular mortality associated with atherosclerosis.